Home/Wayfinder Biosciences/David Sparkman-Yager, PhD

DS

David Sparkman-Yager, PhD

Founder & CTO

Wayfinder Biosciences

Therapeutic Areas

Oncology Neurodegeneration

Wayfinder Biosciences Pipeline

Drug	Indication	Phase
c-MYC Program	Oncology	Discovery/Hit-to-Lead
Undisclosed Program	Neurodegeneration	Target ID/Discovery

Leadership Team at Wayfinder Biosciences

Jason Fontana, PhD

Chuhern Hwang, PhD

Founder & Head of Drug Discovery

Michelle Kriner, PhD

Head of Program Development

Rao Talasila, MSc

Head of Machine Learning

View full Wayfinder Biosciences profile